Aptimmune Biologics
Edit

Aptimmune Biologics

http://aptimmune.com/
Last activity: 01.02.2017
Active
Categories: Industry
Swine Mucosal Vaccines
Mentions
3
Total raised: $2.75M

Investors 3

Funding Rounds 1

DateSeriesAmountInvestors
09.07.2015Series A$2.75M-

Mentions in press and media 3

DateTitleDescription
01.02.2017The Yield Lab Invests $300k in Latest Agritech Cohort Taking Total to $1.8mThe Yield Lab, the accelerator program based in St Louis, Missouri, has made three new investments of $100k each in agritech startups joining its 2017 cohort. This takes The Yield Lab’s total investment in agtech startups to $1.8 million ac...
13.07.2015Aptimmune Biologics Raises $2.75M of Series A CHAMPAIGN, IL, Mucosal vaccine company developing novel swine vaccines for PRRSV and influenza virus, has received $2.75 million of funding. >> Click here for more funding data on Aptimmune Biologics >> To export Aptimmune B...
09.07.2015Aptimmune Biologics Raises $2.75M in FundingAptimmune Biologics, a Champaign, IL-based mucosal vaccine company developing novel swine vaccines for PRRSV and influenza virus, raised $2.75m in funding. Backers included Arsenal Capital Management, Fox Ventures and a group of Midwest ang...

Reviews 0

Sign up to leave a review

Sign up Log In